Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Gilead Sciences, Inc.
Scientific Title
A Phase 2 Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma